We support commercial decision making
At our heart, we deliver analysis and insights to help our clients manage their portfolios and develop their businesses, supporting commercial decision making and identifying new opportunities.
We specialise in early to mid stage clinical opportunities. Our groupH team members have a deep understanding of the key decision points and the data/insights/analysis required to support these decisions. We are also very aware of the commercial constraints within which our clients are operating at this stage of an asset’s evolution.
“groupH is one of the few agencies that I work with who can conduct the secondary analysis, primary qual and primary quant and combine it in a meaningful way for early stage assessments; also at a price point that is appropriate for early stage work.”
Top-10 Pharma company
At groupH our clients benefit by working directly with the same person who will be directly responsible for planning, managing and delivering the projects. Our hands-on approach and extensive experience means we can understand your needs, determine the most appropriate research methodologies, analyse the findings and ultimately distil the critical insights and recommended actions that matter for you.
“The fact that groupH is a boutique agency was an advantage to us, because it meant we could get a tailored approach to our project, great flexibility and direct access to their senior researchers.”
Global Brand Manager, Top-10 Pharma company
At groupH, we pride ourselves on bringing clarity to the decisions our clients make by providing insights that address business critical questions. We seek to provoke new thinking and challenge assumptions based on the insights and evidence that our research generates.
“groupH immediately demonstrated an ability to identify and analyse the key strategic and commercial issues, and showed an impressive understanding of the drug development process. We would seek to engage them again without hesitation.”
Leading private equity firm